Hongwang Xiao

Dr. Hongwang Xiao

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2021 in Journal of Ambient Intelligence and Humanized Computing
Verified
Journal Article
Closed access
PDF file
HXHongwang Xiao
Hongwang Xiao
YYYun Yang
Yun Yang
KYKe Yu
Ke Yu
JTJiao Tian
Jiao Tian
XCXinyi Cai
Xinyi Cai
JCJinjun Chen
Jinjun Chen

1 September 2021
Verified
Conference Paper
Closed access
KYKe Yu
Ke Yu
HXHongwang Xiao
Hongwang Xiao
YZYing Zhao
Ying Zhao
JTJiao Tian
Jiao Tian
JCJinjun Chen
Jinjun Chen
In real-time systems, energy consumption is one of the most critical challenges. Dynamic voltage and frequency scaling (DVFS) algorithms have been widely applied to balance the trade-off between performance and power consumption. We first review some classic DVFS methods, e.g., LA-EDF and CCEDF, and then a hybrid DVFS algorithm (Soft-LA2) that we proposed recently. Soft-LA2 needs domain knowledge to set the trade-off parameter manually to achieve energy saving compared with classic methods. Motivated by recent deep learning technologies applied in DVFS, in this paper, we propose a new framework for Soft-LA2. Our method automatically optimizes parameters for Soft-LA2, which leads to more power saving compared with random parameter setting in Soft-LA2. Simulation results show that under certain neural network architecture setting, our method can find the best parameters automatically to achieve power saving performance. Furthermore, with test data, our proposed method saves 4.9% and 9.6% power consumption compared with relevant learning method DQL-EES and random setting Soft-LA2, respectively.

8 December 2025 in Concurrency and Computation: Practice and Experience
Verified
Journal Article
Closed access
HXHongwang Xiao
Hongwang Xiao
QYQiwei Ye
Qiwei Ye
YSYu Shu
Yu Shu
BLBo Li
Bo Li
YLYao Li
Yao Li
WHWenhao Huang
Wenhao Huang

Verified
Journal Article
Open access
PDF file
KFKeke Fan
Keke Fan
YXYanan Xu
Yanan Xu
QYQiwei Ye
Qiwei Ye
MZMingliang Zeng
Mingliang Zeng
HXHongwang Xiao
Hongwang Xiao
LHLiming Hu
Liming Hu
Endpoint structure–activity relationships (SARs) for irreversible inhibitors can integrate reversible binding, covalent chemistry, conformational behavior, and cellular factors, making it difficult to assign a potency change to a single molecular event. We reanalyzed a previously reported series of irreversible inhibitors of wild-type (WT) HER2 and HER2 A775_G776insYVMA (HER2YVMA) as six matched analogue pairs. Three complementary analyses were kept physically distinct. Pre-reaction molecular dynamics (MD) trajectories were used to quantify the fraction of frames satisfying a predefined near-attack-conformation (NAC)-like distance–angle criterion; continuous structural descriptors calculated from OpenComplex2 (OC2)-generated covalently linked HER2–inhibitor structures were used to characterize structural differences after covalent linkage; and covalent-adduct MD trajectories were used to characterize post-bond-formation dynamics. The Michael addition step itself was neither simulated nor measured. Cyclization of compound 3 to compound 9c increased the NAC-like frame fraction in HER2WT from 0.0217% to 0.358% but decreased it in HER2YVMA from 0.745% to 0.333%, with the overall direction preserved across all six sensitivity definitions. In HER2YVMA, the modification distinguishing compounds 4a and 5a increased the NAC-like fraction from 2.620% to 6.244% despite a loss of cellular potency. The analogous tail modification increased this fraction in the 8c/10e series, whereas the HER2YVMA 9c/11f response was starting conformation sensitive. The distribution of OC2-generated covalently linked structures across the predefined structural coordinate and the final-adduct MD readouts likewise varied with HER2 context and scaffold, although some differential effects were sensitive to the coordinate reference. These analyses complement experimental SARs but do not provide a measure of reaction kinetics or thermodynamic populations.

27 October 2025
Verified
Conference Paper
Open access
YGYongan Guo
Yongan Guo
ZZZhongyan Zhou
Zhongyan Zhou
YWYuao Wang
Yuao Wang
NZNa Zhu
Na Zhu
XZXuyun Zhang
Xuyun Zhang
BLBo Li
Bo Li

25 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
KFKeke Fan
Keke Fan
YXYanan Xu
Yanan Xu
QYQiwei Ye
Qiwei Ye
MZMingliang Zeng
Mingliang Zeng
HXHongwang Xiao
Hongwang Xiao
LHLiming Hu
Liming Hu
Endpoint structure–activity relationships (SAR) for irreversible inhibitors can integrate reversible binding, covalent chemistry, conformational behavior, and cellular factors, making it difficult to assign a potency change to a single molecular event. We reanalyzed a previously reported series of irreversible inhibitors of wild-type (WT) HER2 and HER2 A775_G776insYVMA (HER2YVMA) as six matched analogue pairs. Three complementary analyses were kept physically distinct. Pre-reaction molecular dynamics (MD) trajectories were used to quantify the fraction of frames satisfying a predefined near-attack-conformation (NAC)-like distance–angle criterion; continuous structural descriptors calculated from OC2-generated covalently linked HER2–inhibitor structures were used to characterize structural differences after covalent linkage; and covalent-adduct MD trajectories were used to characterize post-bond-formation dynamics. The Michael-addition step itself was neither simulated nor measured. Cyclization of compound 3 to compound 9c increased the NAC-like frame fraction in HER2WT from 0.0217% to 0.358% but decreased it in HER2YVMA from 0.745% to 0.333%, with the direction preserved across all six sensitivity definitions. In HER2YVMA, the modification distinguishing compounds 4a and 5a increased the NAC-like fraction from 2.620% to 6.244% despite a loss of cellular potency. The analogous tail modification increased this fraction in the 8c/10e series but reduced it in the 9c/11f series. The distribution of OC2-generated covalently linked structures across the predefined structural coordinate and the final-adduct MD readouts likewise varied with HER2 context and scaffold, although some differential effects were sensitive to the coordinate reference. No single structural readout tracked endpoint potency across all six pairs. These analyses complement experimental SAR but do not provide a measure of reaction kinetics or thermodynamic populations.